5,477
edits
Weight loss injections: Difference between revisions
→Tirzepatide (Zepbound/Mounjaro)
No edit summary |
|||
| Line 4: | Line 4: | ||
===Tirzepatide (Zepbound/Mounjaro)=== | ===Tirzepatide (Zepbound/Mounjaro)=== | ||
[[Tirzepatide]], marketed under the brand | [[Tirzepatide]], marketed under the brand names Zepbound/Mounjaro, is a weight loss injection that is currently in development. It works by targeting multiple hormones that regulate appetite and metabolism. Clinical trials have shown promising results in terms of weight loss and blood sugar control. W8MD offers both the brand name Zepbound / Mounjaro and generic compounded options starting from $125.00 biweekly and up with insurance. [[Tirzepatide|Learn more ...]] | ||
===Semaglutide (Wegovy) / Ozempic=== | ===Semaglutide (Wegovy) / Ozempic=== | ||
[[File:W8md weight loss ad with meal replacements.jpg|400px|left|alt=Lose weight in NYC or Philadelphia with W8MD|Lose weight in NYC or Philadelphia with W8MD]] | [[File:W8md weight loss ad with meal replacements.jpg|400px|left|alt=Lose weight in NYC or Philadelphia with W8MD|Lose weight in NYC or Philadelphia with W8MD]] | ||